Barry M. Massie, BA (Harvard), MD (Columbia P&S)
January 6th, 2011
The Shame of Removing Reimbursement for End-of-Life Discussions from Health Care Reform
Barry M. Massie, BA (Harvard), MD (Columbia P&S)
My recent postings have been about heart failure mortality statistics. Dry stuff! It’s not that I am fixated on death, but yesterday, I learned that CMS (Medicare) has decided not to pay for discussions with patients about prognosis and planning end of life care. Reimbursement for such discussions was a key aspect of the health care […]
December 23rd, 2010
Barry Massie: Looking Back at the Year in Heart Failure
Barry M. Massie, BA (Harvard), MD (Columbia P&S)
To celebrate the holiday season, CardioExchange asked several of our contributors to choose the most important cardiology-related events of the past year. Barry Massie has focused on heart failure, providing us with his choice of the four most important stories of 2010. 1. Aldosterone antagonists continue their winning streak: Following the convincing reductions in mortality and morbidity […]
NEJM Journal Watch — Recent Cardiology Articles- Persistent Symptoms After Valve Replacement for Severe Aortic Stenosis
- Is Diltiazem Safe in Patients with AF Taking Apixaban or Rivaroxaban?
- Does Lowering High Childhood Lipid Levels Prevent Adverse Cardiovascular Events in Adulthood?
- Self-Expanding Supraannular Valve vs. Balloon-Expandable Valve in TAVR for Small Aortic Annulus
- A New TAVR Prosthesis for Aortic Regurgitation Shows Promise